Posted: April 16, 2007 at 10:39 am
Peregrine Pharmaceuticals, Inc. (PPHM-NASDAQ) just issued a press release showing "Peregrine's Selective Anti-VEGF Antibodies Inhibited Tumor Growth By 90% In a Preclinical Cancer Model" AND "Shows Peregrine's Selective Anti-VEGF Antibodies ...
Read Full Story »